ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,585
0,05%
Bitcoin
58 920,91
1,17%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Arcturus Therapeutics Holdings Inc (ARCT)

  7. Arcturus Therapeutics Holdings Inc (ARCT) Actualités

ARCT Arcturus Therapeutics Holdings Inc

26,52
-1,39 (-4,98%)
Après les heures de négociation
Dernière mise à jour : 22:02:15
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Arcturus Therapeutics Holdings Inc ARCT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-1,39 -4,98% 26,52 22:02:15
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
28,00 25,995 28,14 26,52 27,91
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202422:01BWArcturus Therapeutics to Report First Quarter Financial..
07/3/202422:05EDGAR2Form 8-K - Current report
07/3/202422:01BWArcturus Therapeutics Announces Fourth Quarter and Fiscal..
26/2/202415:00BWArcturus Therapeutics to Present at the Barclays 26th Annual..
23/2/202422:05EDGAR2Form 8-K - Current report
22/2/202414:30BWArcturus Therapeutics Receives Orphan Medicinal Product..
20/2/202415:00BWArcturus Therapeutics to Report Fourth Quarter and Full Year..
05/2/202414:30PRNUSNew COVID-19 sa-mRNA Results from CSL and Arcturus..
21/12/202314:00PRNUSCSL and Arcturus Therapeutics' ARCT-154 Demonstrates..
20/12/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:30BWArcturus Therapeutics to Present at the 42nd Annual J.P...
28/11/202314:05PRNUSJapan's Ministry of Health, Labour and Welfare Approves CSL..
28/11/202314:00BWJapan's Ministry of Health, Labour and Welfare Approves CSL..
27/11/202315:13DJNArcturus Therapeutics Gets FDA Orphan Designation for..
27/11/202314:30BWArcturus Therapeutics Receives Orphan Drug Designation from..
15/11/202314:51IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
14/11/202322:10EDGAR2Form 8-K - Current report
14/11/202322:01BWArcturus Therapeutics Announces Third Quarter 2023 Financial..
25/10/202322:01BWArcturus Therapeutics to Report Third Quarter Financial..
23/10/202322:01BWArcturus Therapeutics to Attend Upcoming Investor &..
04/10/202314:30BWArcturus Therapeutics Joint Venture mRNA Manufacturing..
26/9/202322:06EDGAR2Form 8-K - Current report
26/9/202314:30BWArcturus Therapeutics and Cystic Fibrosis Foundation Extend..
19/9/202314:30BWStudy Shows Novel sa-mRNA Vaccines Offer Robust, Broad,..
05/9/202314:30BWArcturus Therapeutics and CSL Announce European Medicines..
17/8/202314:30BWArcturus Therapeutics to Attend Upcoming Investor..
14/8/202315:00BWArcturus Therapeutics Joint Venture mRNA Manufacturing..
07/8/202323:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202322:23EDGAR2Form 8-K - Current report
07/8/202322:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/8/202322:01BWArcturus Therapeutics Announces Second Quarter 2023..
03/8/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202322:01BWArcturus Therapeutics to Report Second Quarter 2023..
14/7/202313:53EDGAR2Form 8-K - Current report
30/6/202314:28EDGAR2Form 8-K - Current report
01/6/202314:30BWArcturus Therapeutics Receives U.S. FDA Fast Track..
09/5/202322:01BWArcturus Therapeutics Announces First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
ARCT
Arcturus Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés